Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-8-9
pubmed:abstractText
We have previously reported the molecular detection of peritoneal micrometastases in patients with gastric cancer by quantifying carcinoembryonic antigen (CEA) mRNA in the peritoneal washes. Patients with CEA mRNA exceeding a cutoff value have a significant risk for developing peritoneal carcinomatosis, but optimal treatment for this population remains unknown.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1432-2323
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2083-9
pubmed:dateRevised
2011-1-24
pubmed:meshHeading
pubmed-meshheading:20379713-Adenocarcinoma, pubmed-meshheading:20379713-Antimetabolites, Antineoplastic, pubmed-meshheading:20379713-Carcinoembryonic Antigen, pubmed-meshheading:20379713-Chemotherapy, Adjuvant, pubmed-meshheading:20379713-Disease-Free Survival, pubmed-meshheading:20379713-Drug Combinations, pubmed-meshheading:20379713-Female, pubmed-meshheading:20379713-Humans, pubmed-meshheading:20379713-Kaplan-Meier Estimate, pubmed-meshheading:20379713-Lymphatic Metastasis, pubmed-meshheading:20379713-Male, pubmed-meshheading:20379713-Middle Aged, pubmed-meshheading:20379713-Neoplasm Staging, pubmed-meshheading:20379713-Oxonic Acid, pubmed-meshheading:20379713-Peritoneal Lavage, pubmed-meshheading:20379713-Peritoneal Neoplasms, pubmed-meshheading:20379713-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20379713-Risk Assessment, pubmed-meshheading:20379713-Stomach Neoplasms, pubmed-meshheading:20379713-Tegafur
pubmed:year
2010
pubmed:articleTitle
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR.
pubmed:affiliation
Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan. seito@aichi-cc.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II